Literature DB >> 30242640

A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population.

Xin Dong1, Junfei Zhou1, Xiaojuan Guo2, Yifan Li1, Yuetong Xu1, Qiang Fu1, Yong Lu3, Yi Zheng4.   

Abstract

To characterize the distinctive chest high-resolution computerized tomography (HRCT) features and clinical manifestations of primary Sjögren syndrome (pSS)-related interstitial lung disease (ILD). The demographic data, clinical manifestations, and laboratory and radiological findings of 527 pSS patients were retrospectively analyzed. ILD was defined based on the presences of pulmonary signs in HRCT. Two hundred six of 527 patients were diagnosed as pSS-ILD, and the prevalence was 39.1%. The three most frequent abnormalities in HRCT were reticular pattern (92.7%), ground-glass attenuation (87.4%), and bronchovascular bundle thickening (82%). One hundred twenty-four cases (60.2%) of the pSS-ILD patients had only a single HRCT pattern, which involved 86 non-specific interstitial pneumonitis (NSIP) cases (41.7%), 22 usual interstitial pneumonia (UIP) cases (10.68%), 8 organizing pneumonia (OP) cases (3.9%), and 8 lymphocytic interstitial pneumonia (LIP) cases (3.9%), respectively. Besides, the more important observation was that 82 cases had no less than two HRCT patterns, and NSIP admixed with OP (43.9%), NSIP admixed with UIP (35.4%), and NSIP admixed with LIP (19.5%) were the most frequent. HRCT of pSS-ILD patients demonstrated bilateral infiltrates (99%), with abnormalities predominantly in the lower lobes (89.3%) and subpleural areas (81.1%), and a few lesions were characterized by hilum distributed (8.7%). Pulmonary function tests (PFTs) revealed impaired diffusion capacity for carbon monoxide and total lung capacity, and the rate of small airway lesions in the pSS-ILD patients was 3.5 times higher in patients of pSS. Logistic regression analysis showed that dry cough (OR 59.05), clubbing (OR 6.26), elevated lactate dehydrogenase (OR 21.38) and positive anti-Ro (OR 7.86) were relevant factors of pSS-ILD. ILD is the common pulmonary involvement of pSS and the prevalence of pSS-ILD is 39.1%. The single pattern of NSIP and UIP in HRCT are the commonest, and about 40% of the pSS-ILD patients possess multiple patterns in HRCT. The classification of idiopathic pulmonary fibrosis cannot completely include the pulmonary imaging features of pSS-ILD.

Entities:  

Keywords:  High-resolution computed tomography; Interstitial lung disease; Primary Sjögren syndrome

Mesh:

Year:  2018        PMID: 30242640     DOI: 10.1007/s10067-018-4289-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  29 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: A retrospective analysis of 315 patients.

Authors:  Xiaomei Li; Bei Xu; Yan Ma; Xiangpei Li; Qi Cheng; Ximei Wang; Guosheng Wang; Long Qian; Li Wei
Journal:  Int J Rheum Dis       Date:  2015-04-30       Impact factor: 2.454

Review 3.  Pulmonary manifestations of Sjögren's syndrome.

Authors:  Thomas Flament; Adrien Bigot; Benjamin Chaigne; Helene Henique; Elisabeth Diot; Sylvain Marchand-Adam
Journal:  Eur Respir Rev       Date:  2016-06

4.  A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects.

Authors:  M Pertovaara; E Pukkala; P Laippala; A Miettinen; A Pasternack
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

Review 5.  Pulmonary manifestations of Sjögren's syndrome.

Authors:  George Stojan; Alan N Baer; Sonye K Danoff
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

6.  Chest HRCT findings in patients with primary Sjögren's syndrome.

Authors:  Agata Sebastian; Maria Misterska-Skóra; Jurand Silicki; Maciej Sebastian; Piotr Wiland
Journal:  Adv Clin Exp Med       Date:  2017-10       Impact factor: 1.727

7.  Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment.

Authors:  D Deheinzelin; V L Capelozzi; R A Kairalla; J V Barbas Filho; P H Saldiva; C R de Carvalho
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

8.  Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway.

Authors:  Alexander Espinosa; Valerie Dardalhon; Susanna Brauner; Aurelie Ambrosi; Rowan Higgs; Fransisco J Quintana; Maria Sjöstrand; Maija-Leena Eloranta; Joan Ní Gabhann; Ola Winqvist; Birgitta Sundelin; Caroline A Jefferies; Björn Rozell; Vijay K Kuchroo; Marie Wahren-Herlenius
Journal:  J Exp Med       Date:  2009-07-27       Impact factor: 14.307

Review 9.  Present and future of biologic drugs in primary Sjögren's syndrome.

Authors:  Domenico Sambataro; Gianluca Sambataro; Ylenia Dal Bosco; Riccardo Polosa
Journal:  Expert Opin Biol Ther       Date:  2016-09-20       Impact factor: 4.388

10.  Pulmonary manifestations of Sjögren's syndrome.

Authors:  Ju-Hong Shi; Hong-Rui Liu; Wen-Bing Xu; Rui-E Feng; Zhu-Hua Zhang; Xin-Lun Tian; Yuan-Jue Zhu
Journal:  Respiration       Date:  2009-04-22       Impact factor: 3.580

View more
  19 in total

1.  Sjogren's Syndrome and Pulmonary Disease.

Authors:  Ruben A Peredo; Scott Beegle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary sjogren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian Society of Rheumatology (articular, pulmonary and renal).

Authors:  Virginia Fernandes Moça Trevisani; Alisson Pugliesi; Sandra Gofinet Pasoto; Maria Lucia Lemos Lopes; Lissiane Karine Noronha Guedes; Samira Tatiyama Miyamoto; Marilena Leal Mesquita Silvestre Fernandes; Sonia Cristina de Magalhães Souza Fialho; Aysa César Pinheiro; Laura Caldas Dos Santos; Simone Appenzeller; Tania Fidelix; Sandra Lúcia Euzébio Ribeiro; Danielle Christinne Soares Egypto de Brito; Tatiana Nayara Libório-Kimura; Maria Carmen Lopes Ferreira Silva Santos; Diego Ustárroz Cantali; Juliana D'Agostino Gennari; Vinicius Tassoni Civile; Ana Carolina Pereira Nunes Pinto; César Ramos Rocha-Filho; Fabiola Reis Oliveira; Aline Pereira da Rocha; Valeria Valim
Journal:  Adv Rheumatol       Date:  2022-06-01

3.  Risk factors for progression of interstitial lung disease in Sjögren's syndrome: a single-centered, retrospective study.

Authors:  Shi-Hao He; Yu-Jie He; Kuang-Jin Guo; Xu Liang; Shan-Shan Li; Tian-Fang Li
Journal:  Clin Rheumatol       Date:  2021-11-10       Impact factor: 2.980

4.  Clinical profiles of SS-ILD compared with SS-NILD in a Chinese population: a retrospective analysis of 735 patients.

Authors:  Ting Guo; Yaomei Long; Qinxue Shen; Wei Guo; Wang Duan; Xiaoli Ouyang; Hong Peng
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 5.  Acute fibrinous and organizing pneumonia in a patient with Sjögren's syndrome and Legionella pneumonia: a case report and literature review.

Authors:  Ye Lu; Wei Zheng; Wei Cao; Xianghong Yang; Li Zhao; Yu Chen
Journal:  BMC Pulm Med       Date:  2022-05-24       Impact factor: 3.320

6.  CXCR2 May Serve as a Useful Index of Disease Activity in Interstitial Lung Disease Associated With Primary Sjögren's Syndrome.

Authors:  Xiaofang Zhu; Saisai Lu; Lixia Zhu; Mengjiao Yu; Tingting Wei; Xiaochun Zhu; Dan Chen; Chengshui Chen
Journal:  Front Mol Biosci       Date:  2021-05-13

7.  Quantitative assessment of interstitial lung disease in Sjögren's syndrome.

Authors:  Pablo Guisado-Vasco; Mario Silva; Miguel Angel Duarte-Millán; Gianluca Sambataro; Chiara Bertolazzi; Mauro Pavone; Isabel Martín-Garrido; Oriol Martín-Segarra; José Manuel Luque-Pinilla; Daniele Santilli; Domenico Sambataro; Sebastiano E Torrisi; Ada Vancheri; Marwin Gutiérrez; Mayra Mejia; Stefano Palmucci; Flavio Mozzani; Jorge Rojas-Serrano; Carlo Vanchieri; Nicola Sverzellati; Alarico Ariani
Journal:  PLoS One       Date:  2019-11-08       Impact factor: 3.240

Review 8.  Recent advances in the diagnosis and management of interstitial pneumonia with autoimmune features: the perspective of rheumatologists.

Authors:  Hong Ki Min; Se-Hee Kim; Sang-Heon Lee; Hae-Rim Kim
Journal:  Korean J Intern Med       Date:  2021-02-08       Impact factor: 2.884

Review 9.  Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them?

Authors:  Domenico Sambataro; Gianluca Sambataro; Francesca Pignataro; Giovanni Zanframundo; Veronica Codullo; Evelina Fagone; Emanuele Martorana; Francesco Ferro; Martina Orlandi; Nicoletta Del Papa; Lorenzo Cavagna; Lorenzo Malatino; Michele Colaci; Carlo Vancheri
Journal:  Diagnostics (Basel)       Date:  2020-04-09

10.  Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases.

Authors:  Andreina Manfredi; Giulia Cassone; Caterina Vacchi; Fabrizio Pancaldi; Giovanni Della Casa; Stefania Cerri; Lisa De Pasquale; Fabrizio Luppi; Carlo Salvarani; Marco Sebastiani
Journal:  Arch Rheumatol       Date:  2020-06-25       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.